Nevertheless, we showed that the plasma CAIX detected in patients with NSCLC is much lower than CAIX concentrations described in renal cell carcinoma, because the very high constitutive HIF-1α levels in these latter tumours and also differences in CAIX expression depending on the cell type (Li et al, 2008). This evidence concerns the gene HIF1A and hereditary clear cell renal cell carcinoma.